您使用提示模式 关闭

FXH - First Trust Health Care AlphaDEX Fund (USD) (US33734X1431)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
US33734X1431
FXH ISIN
交易所交易基金 (ETF)
基金类型
First Trust
提供商
117,58 USD
每股资产净值 | 2026-06-12
2007-05-08
成立日期
4 每年的次数
股息的支付
CEOJLS
CFI
FXH
代码
Formed
Status
Equity
投资项目
Healthcare
部门
USA
地区分布
StrataQuant(R) Health Care Index.
基准
0.62 %
总成本比率
893,59 百万 USD
基金资产总量 | 2026-06-12
893,59 百万 USD
股票类资产 | 2026-06-12
否
UCITS

收益率 在 2026-06-12, NYSE Arca

  • YTD
    -1,11 %
  • 1M
    -1,3 %
  • 3M
    -1,89 %
  • 6M
    1,42 %
  • 1Y
    10,58 %
  • 3Y
    8,75 %
  • 5Y
    2,21 %
  • 10Y
    101,62 %
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (FXH)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

FXH profile

The First Trust Health Care AlphaDEX Fund (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The First Trust fund’s base currency is USD and the share class was registered 08.05.2007 with unique ISIN - US33734X1431. Main exchange is NYSE Arca and ticker symbol is FXH. The total expense ratio is 0.62%. The First Trust Health Care AlphaDEX Fund (USD) pays dividends 4 time(s) per year.

结构 FXH 在 2026-06-12

下载结构至 Excel 文档
证券 值
Humana Inc. 4,61%
Organon & Co. 3,79%
Elevance Health Inc. 2,91%
DaVita Inc. 2,86%
Exelixis, Inc. 2,61%
Solventum Corporation 2,55%
Molina Healthcare, Inc. 2,54%
Incyte Corporation 2,43%
The Cigna Group 2,36%
Biogen Inc. 2,3%
Cardinal Health, Inc. 2,24%
Bio-Rad Laboratories, Inc. (Class A) 2,16%
Zimmer Biomet Holdings, Inc. 2,07%
Globus Medical, Inc. (Class A) 1,97%
Chemed Corporation 1,87%
Encompass Health Corporation 1,77%
Universal Health Services, Inc. (Class B) 1,73%
HCA Healthcare, Inc. 1,73%
Amgen Inc. 1,7%
Merck & Co., Inc. 1,67%
Regeneron Pharmaceuticals, Inc. 1,67%
Illumina, Inc. 1,65%
Ionis Pharmaceuticals, Inc. 1,65%
Penumbra, Inc. 1,64%
Pfizer Inc. 1,58%
Becton, Dickinson and Company 1,57%
QIAGEN N.V. 1,56%
Tenet Healthcare Corporation 1,56%
United Therapeutics Corporation 1,55%
Revvity, Inc. 1,44%
Henry Schein, Inc. 1,4%
Natera, Inc. 1,34%
Quest Diagnostics Incorporated 1,31%
UnitedHealth Group Incorporated 1,27%
Labcorp Holdings Inc. 1,26%
The Cooper Companies, Inc. 1,2%
Steris Plc 1,19%
Bristol-Myers Squibb Company 1,19%
Medtronic Plc 1,17%
GE HealthCare Technologies Inc. 1,16%
Certara, Inc. 1,15%
Gilead Sciences, Inc. 1,14%
ResMed Inc. 1,1%
Eli Lilly and Company 1,04%
Neurocrine Biosciences, Inc. 1,02%
Insmed Incorporated 1,01%
Waters Corporation 1,01%
Agilent Technologies, Inc. 0,96%
Halozyme Therapeutics, Inc. 0,91%
IQVIA Holdings Inc. 0,9%
Sarepta Therapeutics, Inc. 0,89%
Align Technology, Inc. 0,86%
BioMarin Pharmaceutical Inc. 0,84%
Johnson & Johnson 0,83%
Medpace Holdings, Inc. 0,82%
Thermo Fisher Scientific Inc. 0,81%
Abbott Laboratories 0,72%
Medline Inc. (Class A) 0,69%
Zoetis Inc. 0,57%
West Pharmaceutical Services, Inc. 0,52%
DexCom, Inc. 0,47%
Royalty Pharma Plc (Class A) 0,45%
Sotera Health Company 0,45%
Edwards Lifesciences Corporation 0,42%
AbbVie Inc. 0,41%
IDEXX Laboratories, Inc. 0,39%
Vertex Pharmaceuticals Incorporated 0,39%
Danaher Corporation 0,38%
Envista Holdings Corporation 0,38%
Stryker Corporation 0,38%
Veeva Systems Inc. (Class A) 0,36%
Intuitive Surgical, Inc. 0,35%
Viking Therapeutics, Inc. 0,35%
Alnylam Pharmaceuticals, Inc. 0,34%
Boston Scientific Corporation 0,3%
US Dollar 0,13%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权